1. Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study1. Issue 6 (9th January 2013) Authors: Ribera, E; Larrousse, M; Curran, A; Negredo, E; Clotet, B; Estrada, V; Sanz, J; Berenguer, J; Rubio, R; Pulido, F; Ferrer, P; Alvarez, ML; Arterburn, S; Martínez, E Journal: HIV medicine Issue: Volume 14:Issue 6(2013:Jul.) Page Start: 327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗